Asian Patients with Chronic Genotype 2 HCV Infection Achieve 98% Sustained Virologic Response Following 12 Week administration of Sofosbuvir in Combination with Ribavirin: Integrated analysis of Phase 3 Multicenter Studies
Resource
Hepatology, 62, 739A-740A
Journal
Hepatology
Journal Issue
62
Pages
-
Date Issued
2015
Date
2015
Author(s)
Omata, Masao
Lim, Young-Suk
Chuang, Wan-Long
Kao, Jia-Horng
Gao, Bing
De-Oertel, Shampa
Yang, Jenny C.
Mo, Hongmei
Brainard, Diana M.
Knox, Steven J.
McHutchison, John G.
Mizokami, Masashi
Han, Kwang-Hyub
